Drug profile · INN
warfarin potassium
ATHROMBIN-K
warfarin potassium (ATHROMBIN-K) is a vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — warfarin potassium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
warfarin potassium (ATHROMBIN-K) is a vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor
Primary target: Vitamin K epoxide reductase complex subunit 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is warfarin potassium?
warfarin potassium (ATHROMBIN-K) is a vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for warfarin potassium?
ATHROMBIN-K is a marketed brand name for warfarin potassium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of warfarin potassium?
warfarin potassium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.